Sage CEO sees strong sales for new postpartum depression pill

The pill, called Zurzuvae, has generated lots of interest among psychiatrists, OB-GYNs, and primary care physicians, the executive said.

Related Keywords

New York ,United States ,Greene ,Cambridge ,Cambridgeshire ,United Kingdom ,Brian Abrahams ,Kristina Deligiannidis ,National Institute Of Mental Health ,American College Of Obstetricians ,Feinstein Institutes For Medical Research In Manhasset ,Drug Administration ,Cambridge Based Biogen ,Feinstein Institutes ,Medical Research ,American College ,National Institute ,Wall Street , ,